PRESS RELEASE published on 12/03/2024 at 15:00, 1 year 5 months ago Viromed Medical AG is expanding its Management Board – Christian Strauch has been appointed as a new member of the Management Board Viromed Medical AG appoints Christian Strauch as new Management Board member to enhance global marketing of cold plasma technology. Uwe Perbandt named Chairman Management Board Viromed Medical AG Global Marketing Cold Plasma Technology Christian Strauch
BRIEF published on 12/03/2024 at 13:58, 1 year 5 months ago Viromed Medical AG Announces Plan to Acquire pharmedix GmbH Acquisition Healthcare Capital Increase Viromed Medical AG Pharmedix GmbH
BRIEF published on 12/03/2024 at 13:58, 1 year 5 months ago Viromed Medical AG annonce son projet d'acquisition de pharmedix GmbH Acquisition Augmentation De Capital Soins De Santé Viromed Medical AG Pharmedix GmbH
PRESS RELEASE published on 12/03/2024 at 13:53, 1 year 5 months ago EQS-Adhoc: Viromed Medical AG plans to acquire all shares in pharmedix GmbH by means of a capital increase against a contribution in kind, excluding subscription rights. Viromed Medical AG plans to acquire pharmedix GmbH through a capital increase, expanding their healthcare portfolio. The acquisition aims for a revenue growth of 35% in 2025 Acquisition Revenue Growth Capital Increase Viromed Medical AG Pharmedix GmbH
BRIEF published on 11/29/2024 at 15:11, 1 year 5 months ago Viromed Medical AG Halts Acquisition Plans, Shifts Focus to Strategic Innovation Strategic Focus Viromed Medical AG ActivCell Group AG ViroCAP Device Acquisition Halt
BRIEF published on 11/29/2024 at 15:11, 1 year 5 months ago Viromed Medical AG met fin à ses projets d'acquisition et se concentre sur l'innovation stratégique Orientation Stratégique Viromed Medical AG Groupe ActivCell SA Dispositif ViroCAP Arrêt De L'acquisition
PRESS RELEASE published on 11/29/2024 at 15:06, 1 year 5 months ago EQS-Adhoc: Viromed Medical AG will not acquire ActivCell Group AG and is focusing on another strategic option with greater added value Viromed Medical AG cancels acquisition of ActivCell Group AG, exploring more valuable strategic options. Focus shifts to advancing innovative medical device ViroCAP Acquisition Strategic Options Viromed Medical AG ViroCAP Innovative Medical Device
BRIEF published on 11/26/2024 at 08:05, 1 year 5 months ago Viromed Medical AG Advances Cold Plasma Research for Lung Health Healthcare Innovation Antibiotic Resistance Viromed Medical AG Cold Plasma Ventilator-associated Pneumonia
BRIEF published on 11/26/2024 at 08:05, 1 year 5 months ago Viromed Medical AG fait progresser la recherche sur le plasma froid pour la santé pulmonaire Résistance Aux Antibiotiques Viromed Medical AG Plasma Froid Innovation Dans Le Domaine De La Santé Pneumonie Associée À La Ventilation Mécanique
PRESS RELEASE published on 11/26/2024 at 08:00, 1 year 5 months ago Viromed Medical AG: cold plasma as a digital antibiotic for the lungs Viromed Medical AG is advancing research into cold plasma as a 'digital antibiotic' for improving treatment of ventilator-associated pneumonia, with potential to revolutionize healthcare Viromed Medical AG Cold Plasma Ventilator-associated Pneumonia Healthcare Revolution Digital Antibiotic
Published on 05/09/2026 at 01:30, 2 days 5 hours ago Star Copper Announces Agreement with Zimtu Capital Corp.
Published on 05/09/2026 at 00:00, 2 days 7 hours ago Onco-Innovations Progresses Toward IND Preparation as Nucro-Technics Commences Bioanalysis for PNKP Inhibitor Technology
Published on 05/11/2026 at 07:11, 12 minutes ago ams-OSRAM AG: Convocation of the Annual General Meeting 2026
Published on 05/11/2026 at 07:10, 13 minutes ago Readcrest Capital realigns its construction project in Halle
Published on 05/11/2026 at 07:10, 13 minutes ago Hypoport delivered gross profit growth and a marked increase in EBIT at the start of 2026.
Published on 05/11/2026 at 07:08, 15 minutes ago EQS-Adhoc: ams-OSRAM AG: ams OSRAM has published the proposals for the Annual General Meeting 2026
Published on 05/11/2026 at 07:00, 23 minutes ago Aurubis AG: Aurubis delivers improved performance: Increased quarterly result and higher forecast
Published on 05/07/2026 at 19:15, 3 days 12 hours ago 2026 Annual General Meeting: approval of all resolutions submitted to the Meeting
Published on 05/07/2026 at 19:15, 3 days 12 hours ago Assemblée Générale annuelle 2026 : approbation de l’ensemble des résolutions soumises au vote
Published on 05/07/2026 at 19:06, 3 days 12 hours ago Disclosure of Share Capital and Voting Rights as of April 30, 2026
Published on 05/07/2026 at 19:06, 3 days 12 hours ago Déclaration du nombre d’actions et droits de vote au 30 avril 2026
Published on 05/07/2026 at 19:00, 3 days 12 hours ago ALTAREIT - INFORMATION RELATIVE AU NOMBRE TOTAL DE DROITS DE VOTE ET D’ACTIONS COMPOSANT LE CAPITAL SOCIAL